Progression to bone-marrow carcinomatosis and extraosseous legion during treatment with radium-223 for multiple bone metastases

A 67-year-old man with metastatic prostate cancer presented with progression to castration-resistant prostate cancer. After sequential therapies with flutamide, estramustine phosphate, docetaxel, enzalutamide, and cabazitaxel for castration-resistant prostate cancer, radium-223 was initiated and con...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int Cancer Conf J
Egile Nagusiak: Hajime, Takahiko, Shiota, Masaki, Abe, Tatsuro, Takeuchi, Ario, Baba, Shingo, Inokuchi, Junichi, Tatsugami, Katsunori, Oda, Yoshinao, Honda, Hiroshi, Eto, Masatoshi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Japan 2017
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6498389/
https://ncbi.nlm.nih.gov/pubmed/31149514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-017-0316-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak